Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Proton-pump inhibitors" wg kryterium: Temat


Wyświetlanie 1-5 z 5
Tytuł:
Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study
Autorzy:
Krzych, Łukasz
Łój, Piotr
Nowak, Teresa
Kazura, Wojciech
Knapik, Piotr
Powiązania:
https://bibliotekanauki.pl/articles/1038596.pdf
Data publikacji:
2017
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
proton-pump inhibitors
hypomagnesaemia
critically ill
Opis:
Many studies have suggested a link between long-term PPI treatment and hypomagnesaemia, though none of them investigated the short-term exposure in high-risk patients. We sought to investigate this issue in 90 critically ill patients. We assessed serum Mg concentrations, necessity of Mg supplementation, PPI dose, duration of PPI therapy and route of administration. In multiple analysis we found that Mg supplementation (positive effect/p=0.03) and enteral route of PPI administration (negative effect/p=0.02) had significant impact on Mg concentration. Although the deleterious relationship between short-term PPI treatment and Mg concentration was found, further studies should be provided to confirm this interesting effect.
Źródło:
Acta Biochimica Polonica; 2017, 64, 3; 499-501
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Using proton-pump inhibitors among hemodialysis patients - single academic dialysis center’s preliminary experience
Autorzy:
Rakowska, M.
Brzósko, S.
Dąbrowska, E.
Jabłońska, E.
Szczykowska, J.
Prusator, P.
Kwaśniewska, A.
Naumnik, B.
Powiązania:
https://bibliotekanauki.pl/articles/1918465.pdf
Data publikacji:
2017
Wydawca:
Uniwersytet Medyczny w Białymstoku
Tematy:
Proton-pump inhibitors
hemodialysis
overuse
side effects
nephrology
Opis:
Introduction: Proton-pump inhibitors (PPIs) are a class of drugs which decrease gastric acid production, their overuse is becoming increasingly common. Purpose: The aim of this study was to evaluate medical indications for PPIs in a cohort of prevalent hemodialysis (HD) patients and their awareness about the medical effects of these drugs. Materials and methods: The study was performed in 78 HD patients enrolled in a chronic dialysis program in a single academic dialysis unit. The study was based on medical history obtained from the patients (survey about drugs they take with intention of revealing PPIs, indications for the treatment, their awareness of the mechanism of action of these drugs).Results: 46 patients (59%) took or have been taking PPIs. Almost half (49%; n=22) had no clear medical indications for the drugs. Prescription of PPIs without medical indications was more common among nephrologists (27%), when compared with gastroenterologists (5%; p<0.05). Only 29% (n=13) of patients taking PPIs were aware of the mechanism of action of the drugs. Conclusions: Results of this study reveal the problem of PPI overuse among HD patients. Gastroenterologists usually prescribed PPIs according to medical indications. Lack of patients’ knowledge about the indications for PPI therapy is overwhelming.
Źródło:
Progress in Health Sciences; 2017, 7(1); 39-43
2083-1617
Pojawia się w:
Progress in Health Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Laryngological symptoms of gastroesophageal reflux disease
Autorzy:
Mierzwa, Grażyna
Sinkiewicz, Anna
Powiązania:
https://bibliotekanauki.pl/articles/1400277.pdf
Data publikacji:
2017
Wydawca:
Index Copernicus International
Tematy:
gastroesophageal reflux disease
laryngopharyngeal reflux
extraesophageal symptoms
proton pump inhibitors
treatment
Opis:
The artical presents a case of a 32 years old men with extraoesophagal symptoms of gastroesohagal reflux disease and laryngopharyngeal reflux. He was by ph-impedance monitoring, stroboskopy and gastrointestinal endoscopy with biopsy diagnosed. PPI therapy with dexlansoprasole was most efficient.
Źródło:
Polski Przegląd Otorynolaryngologiczny; 2017, 6, 2; 70-75
2084-5308
2300-7338
Pojawia się w:
Polski Przegląd Otorynolaryngologiczny
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Treatment of Tropical Diseases
Autorzy:
Das, Nitisranjan
Das, Nirajranjan
Powiązania:
https://bibliotekanauki.pl/articles/1193036.pdf
Data publikacji:
2016
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Tropical diseases
adverse effects
antiparasitic
brand names
drugs
generia names
proton pump inhibitors
Opis:
Tropical diseases found in tropics are mostly contagious and vector borne. Here in the tropics as there is moisture in the air and hot climate sustained for a long time in the year the spread of the pathogens causing the diseases is very much congenial. This hand book written on the treatment of tropical diseases will help the practicing Physicians to choose the most appropriate drug for the treatment. Here therapeutic drugs are highlighted according to their uses. The dominant symptoms, pathogens, area of endemic and epidemic diseases are focussed in coloured world map along with pathogenecity. The generic and brand names of the drugs along with the names of the manufacturing company are mentioned. The adverse effects of the drugs are also discussed.
Źródło:
World Scientific News; 2016, 45, 1; 1-62
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Occupational contact allergy to omeprazole and ranitidine
Autorzy:
Herrera-Mozo, Inmaculada
Sanz-Gallen, Pere
Martí-Amengual, Gabriel
Powiązania:
https://bibliotekanauki.pl/articles/2164096.pdf
Data publikacji:
2017-05-16
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
occupational exposure
occupational contact dermatitis
proton pump inhibitors
ranitidine
omeprazole
active pharmaceutical ingredients
Opis:
Omeprazole is a proton pump inhibition and ranitidine is an H2 histamine receptor antagonist widely used in the treatment of gastroesophageal reflex disease, peptic ulcer disease, Zollinger-Ellison syndrome and as a protector of the gastric mucosae. We report a case of occupational contact allergy to omeprazole and ranitidine. A 48-year-old man, with no pre-existing history of atopy or lifestyle factors. He neither had any medical history of consumption of drugs such as ranitidine and omeprazole. He worked for 19 months in the pharmaceutical company that manufactured ranitidine base. He presented rash in the face and eczema on the dorsum of the hands with itching. The study by prick tests with ranitidine gave negative response. Patch testing with ranitidine base and ranitidine hydrochloride gave positive response. A month later, when the patient was asymptomatic he returned to the pharmaceutical company, being switched from this previous job to the reactor manufacturing omeprazole. A few days after that, he presented erythematous eruptions involving face and neck with itching. Prick tests, path tests and in vitro laboratories studies with omeprazole gave positives. In this case the patient presented hypersensitivity type I at omeprazole and hypersensitivity type IV at omeprazole and ranitidine. Our aportation indicates the importance of careful analysis of the occupational exposure histories of patients with the suspected type I or type IV hypersensitivity to allergens, to determine whether work exposure is the cause. Med Pr 2017;68(3):433–435
Źródło:
Medycyna Pracy; 2017, 68, 3; 433-435
0465-5893
2353-1339
Pojawia się w:
Medycyna Pracy
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies